Biosecure Act
The Biosecure Act, or H.R. 8333, was a bill introduced during the 118th United States Congress that prohibits entities that receive federal funds from using biotechnology that is from a company associated with a U.S. foreign adversary.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
The Biosecure Act, or H.R. 8333, was a bill introduced during the 118th United States Congress that prohibits entities that receive federal funds from using biotechnology that is from a company associated with a U.S. foreign adversary. However, the bill was not included in the last legislation during the 118th United States Congress and as a result, it did not become law in 2024.
It became law in 2025 and in June 2026 the Department of Defense included WuXi AppTec in its list "1260H list" of “Chinese military companies” operating in the US.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1369096632 under CC BY-SA 4.0; modifications have been made.